Supplementing IPA to PCOS model mice can activate the aryl hydrocarbon receptor (AhR), inhibit the activation of NLRP3 inflammasome and NF-κB pathway, and reduce the release of pro-inflammatory factors to alleviate ovarian inflammation. This evidence concerns the gene AHR and polycystic ovary syndrome.